MedPath

the therapeutic effects of vaginal cream of bunium persicum (black zera) on candida albicans vaginitis

Phase 2
Recruiting
Conditions
Vulvo vaginal Candidiasis.
Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
N77.1
Registration Number
IRCT20200415047087N1
Lead Sponsor
Jeeroft University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Married women in the age range of 15-49 years
No pregnancy or breastfeeding
Do not use oral or topical antifungals to treat vaginal infections in the last two weeks
Lack of sensitivity to clotrimazole and black cumin
Lack of use of antibiotics and immunosuppressive drugs in the last two weeks
Not suffering from chronic diseases such as diabetes

Exclusion Criteria

More than once forgetting to use medication
Sensitivity or intolerance to the drug used
get pregnant
Abnormal vaginal bleeding
Lack of willingness to cooperate with participants

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of women with positive vaginal discharge for candid vaginitis. Timepoint: 1 and 8 day. Method of measurement: Chromium agar culture medium.
Secondary Outcome Measures
NameTimeMethod
Cultivation of vaginal secretions for candid vaginitis. Timepoint: 8 day. Method of measurement: Chromium agar culture medium.
© Copyright 2025. All Rights Reserved by MedPath